atorvastatin has been researched along with Melanoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hosaka, YZ; Ishikawa, T; Osaki, T; Sugiura, A; Tashiro, J; Warita, K; Warita, T | 1 |
| Boros, LG; Collins, TQ; D'Agostino, DP; Hitendra, P; Meuillet, EJ; Somlyai, G | 1 |
| Hohenegger, M; Minichsdorfer, C | 1 |
| Carranza, DC; Chen, IY; Collisson, EA; Kolodney, MS | 1 |
| Collisson, EA; De, A; Gambhir, SS; Kleer, C; Kolodney, MS; Merajver, SD; Wu, M | 1 |
| Dellavalle, RP; Drake, AL; Freeman, SR; Graber, M; Heilig, LF; McNealy, K; Schilling, LM | 1 |
2 review(s) available for atorvastatin and Melanoma
| Article | Year |
|---|---|
Structural homologies between phenformin, lipitor and gleevec aim the same metabolic oncotarget in leukemia and melanoma.
Topics: Atorvastatin; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanoma; Metformin; Phenformin | 2017 |
Statins, fibrates, and melanoma risk: a systematic review and meta-analysis.
Topics: Atorvastatin; Bezafibrate; Clofibrate; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Incidence; Lovastatin; Melanoma; Odds Ratio; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Reproducibility of Results; Simvastatin; Skin Neoplasms; United States | 2006 |
4 other study(ies) available for atorvastatin and Melanoma
| Article | Year |
|---|---|
Atorvastatin preferentially inhibits the growth of high ZEB-expressing canine cancer cells.
Topics: Animals; Atorvastatin; Cell Line, Tumor; Cell Proliferation; Dog Diseases; Dogs; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Melanoma | 2022 |
Autocrine amplification loop in statin-induced apoptosis of human melanoma cells.
Topics: Antineoplastic Agents; Apoptosis; Atorvastatin; Autocrine Communication; Biological Factors; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Enzyme Activation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Melanoma; Pyridines; Pyrroles; Simvastatin; Time Factors | 2009 |
Isoprenylation is necessary for the full invasive potential of RhoA overexpression in human melanoma cells.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Biocompatible Materials; Cell Movement; Collagen; Drug Combinations; Gene Expression Regulation, Neoplastic; Heptanoic Acids; Humans; Laminin; Melanoma; Neoplasm Invasiveness; Neoplasm Metastasis; Protein Prenylation; Protein Processing, Post-Translational; Proteoglycans; Pyrroles; rhoA GTP-Binding Protein; Signal Transduction; Skin Neoplasms; Transcription, Genetic; Tumor Cells, Cultured | 2002 |
Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells.
Topics: Animals; Atorvastatin; Cell Movement; Green Fluorescent Proteins; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunoblotting; Immunohistochemistry; Luciferases; Luminescent Proteins; Melanoma; Mice; Mice, SCID; Microscopy, Fluorescence; Neoplasm Invasiveness; Neoplasm Metastasis; Plasmids; Protein Processing, Post-Translational; Pyrroles; ras Proteins; rho GTP-Binding Proteins; rhoC GTP-Binding Protein; Serum Response Factor; Subcellular Fractions; Time Factors; Tumor Cells, Cultured | 2003 |